In this regard, familial ovarian cancers have a higher frequency of p53 mutations than sporadic cancers [14], and it has been suggested that loss of p53 function is required for a cell to tolerate the loss of the Brca1 function [57]–[59]. The gene discussed is TP53; the disease is familial ovarian cancer.